首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1907998

鴉片類藥物市場按藥物類別、用途、給藥途徑、分銷管道和地區分類

Opioid Drugs Market, By Drug Class, By Application, By Route of Administration, By Distribution Channel, By Geography

出版日期: 2025年12月24日 | 出版商:

Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2025 年，鴉片類藥物市場價值將達到 480.2 億美元，到 2032 年將達到 602.7 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 3.3%。

報告覆蓋範圍		報告詳情
基準年：	2024	2025年市場規模：	480.2億美元
歷史數據時期：	2020年至2024年	預測期：	2025年至2032年
預測期（2025-2032年）複合年成長率：	3.30%	2032 年的預測值：	602.7億美元

鴉片類藥物是一類主要用於緩解疼痛的藥物。氫可酮是最早的鴉片類藥物之一，於1803年研發成功。鴉片類藥物作用於中樞和周邊神經系統中的鴉片受體，進而緩解疼痛。鴉片類藥物的給藥途徑包括口服片劑、注射劑、液體劑型、貼片和錠劑。處方箋鴉片類藥物包括Fentanyl、羥考酮、氫可酮、可待因、oxymorphone和氫可酮，由醫生開立用於疼痛管理。

市場動態

針對鴉片受體和神經激肽受體的雜合化合物合成的研究與開發不斷加強，預計將為市場相關人員創造盈利的成長機會。例如，2019年12月，羅茲醫科大學的研究人員報告了一系列雜合化合物的合成、構效關係和藥理學表徵，這些化合物將鴉片類藥物的藥理基團與P物質（SP）片段或神經激肽受體（NK1）拮抗劑片段相結合，探討了神經激肽系統在鴉片類藥物誘導的鎮痛作用中的作用。

市場上的主要企業正專注於產品核可和上市，以拓展產品系列。例如，2018年6月，專業製藥公司AcelRx Pharmaceuticals, Inc.的DZUVEO獲得歐盟委員會（EC）核准，用於在醫療監督下治療成人急性中度至重度疼痛。此外，市場併購活動也正在增加。例如，Grunenthal收購了美國製藥公司Averitas Pharma，以拓展其在美國的業務。

本次調查的主要特點

本報告以 2024 年為基準年，介紹了全球鴉片類藥物市場的規模，並對 2025 年至 2032 年的預測期進行了詳細分析。
它重點介紹了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
該研究還提供了有關市場促進因素、限制因素、機會、新產品發布或核准、區域前景以及主要企業採取的競爭策略的重要見解。
該報告根據以下參數對全球鴉片類藥物市場的主要企業進行了分析：公司概況、財務業績、產品系列、地理分佈、分銷策略、關鍵發展和策略以及未來計劃。
本報告的研究結果將幫助負責人和經營團隊就未來的產品推出、技術升級、市場擴張和行銷策略做出明智的決策。
這份全球鴉片類藥物市場報告的目標受眾是該行業的各類相關人員，包括投資者、供應商、製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過各種用於分析全球鴉片類藥物市場的策略矩陣輕鬆做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太地區
中東
- GCC
- 以色列
- 其他中東地區
非洲
- 北非
- 中非
- 南非

第9章競爭情勢

公司簡介
- Teva Pharmaceutical Industries Ltd.
- Johnson &Johnson
- Endo International plc
- Lupin Limited
- Cadila Healthcare Limited
- Purdue Pharma LP
- AbbVie Inc.
- Fresenius Kabi
- Mallinckrodt Pharmaceuticals
- Pfizer Inc.
- Rhodes Pharmaceuticals LP
- Sun Pharmaceutical Industries Limited
- Nesher Pharmaceuticals（USA）LLC
- Amneal Pharmaceuticals LLC
- Trevena Inc.
- Aurobindo Pharma Limited

第10章各節

參考
調查方法

簡介目錄

Product Code: CMI1017

Opioid Drugs Market is estimated to be valued at USD 48.02 Bn in 2025 and is expected to reach USD 60.27 Bn by 2032, growing at a compound annual growth rate (CAGR) of 3.3% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 48.02 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	3.30%	2032 Value Projection:	USD 60.27 Bn

Opioids are a class of drugs which are largely used for relieving pain. One of the first opioid drugs 'morphine' was developed in 1803. Opioid drugs act on the opioid receptors present in the central and peripheral nervous system thus providing relief from pain. Opioid are administered in the form of as oral pills, parenteral, liquids, patches or lozenges. There are different types of prescription opioids available such as fentanyl, oxycodone, morphine, codeine, oxymorphone, and hydrocodone which are prescribed by physicians for treating pain.

Market Dynamics

Increasing R&D in synthesis of hybrids targeting opioid and neurokinin receptors is expected to offer lucrative growth opportunities for market players. For instance, in December 2019, researchers from Medical University of Lodz reported the synthesis, structure-activity relationship, and pharmacological characterization of a series of hybrids combining opioid pharmacophores with either substance P (SP) fragments or neurokinin receptor (NK1) antagonist fragments in order to comprehend the role of the neurokinin system in opioid-induced antinociception.

Key players in the market are focused on product approvals and launches to expand their product portfolio. For instance, in June 2018, AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company received the European Commission (EC) approval for DZUVEO for the management of acute moderate to severe pain in adults in medically monitored settings. The market is witnessing increasing merger and acquisition activities. For instance, Grunenthal acquired the U.S.-based pharmaceutical company 'Averitas Pharma' in order to expand its presence in the U.S.

Key features of the study

This report provides an in-depth analysis of global opioids market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global opioids market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., Johnson & Johnson, Endo International plc, Lupin Limited, Cadila Healthcare Limited, Purdue Pharma L.P., AbbVie Inc., Fresenius Kabi, Mallinckrodt Pharmaceuticals, Pfizer Inc., Rhodes Pharmaceuticals L.P., Sun Pharmaceutical Industries Limited, Nesher Pharmaceuticals (USA) LLC, Amneal Pharmaceuticals LLC, Trevena Inc., and Aurobindo Pharma Limited
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global opioids market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global opioids market

Market Segmentation

Drug Class Insights (Revenue, USD Bn, 2025 - 2032)
- Alkaloids
- Semisynthetic Opioids
- Synthetic Opioids
Application Insights (Revenue, USD Bn, 2025 - 2032)
- Analgesia
- Cough Suppression
- Diarrhea Suppression
Route of Administration Insights (Revenue, USD Bn, 2025 - 2032)
- Oral
- Topical
- Parenteral
- Others
Distribution Channel Insights (Revenue, USD Bn, 2025 - 2032)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Regional Insights (Revenue, USD Bn, 2025 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Key Players Insights
- Teva Pharmaceutical Industries Ltd.
- Johnson & Johnson
- Endo International plc
- Lupin Limited
- Cadila Healthcare Limited
- Purdue Pharma L.P.
- AbbVie Inc.
- Fresenius Kabi
- Mallinckrodt Pharmaceuticals
- Pfizer Inc.
- Rhodes Pharmaceuticals L.P.
- Sun Pharmaceutical Industries Limited
- Nesher Pharmaceuticals (USA) LLC
- Amneal Pharmaceuticals LLC
- Trevena Inc.
- Aurobindo Pharma Limited

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Drug Class
- Market Snippet, By Application
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Product Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
Reimbursement Scenario
PEST Analysis
PORTER'S Analysis

4. Global Opioid Drugs Market, By Drug Class, 2020- 2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Alkaloids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Segment Trends
  - Morphine
  - codeine
Semisynthetic Opioids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Segment Trends
  - Oxycodone
  - Hydrocodone
  - Hydromorphone
Synthetic Opioids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Segment Trends
  - Fentanyl
  - Alfentanil

5. Global Opioid Drugs Market, By Application, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Analgesia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Segment Trends
Cough Suppression
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Segment Trends
Diarrhea Suppression
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Segment Trends

6. Global Opioid Drugs Market, By Route of Administration, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Segment Trends
Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Segment Trends
Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Segment Trends
Others (Intramuscular, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Segment Trends

7. Global Opioid Drugs Market, By Distribution Channel, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Opioid Drugs Market, By Region, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
North America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020-2032, (USD Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020-2032, (USD Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2020-2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020-2032, (USD Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020-2032, (USD Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020-2032, (USD Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020-2032, (USD Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- Teva Pharmaceutical Industries Ltd.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Johnson & Johnson
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Endo International plc
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Lupin Limited
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Cadila Healthcare Limited
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Purdue Pharma L.P.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- AbbVie Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Fresenius Kabi
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Mallinckrodt Pharmaceuticals
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Pfizer Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Rhodes Pharmaceuticals L.P.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Sun Pharmaceutical Industries Limited
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Nesher Pharmaceuticals (USA) LLC
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Amneal Pharmaceuticals LLC
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Trevena Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Aurobindo Pharma Limited
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies